Benchmark trims Cinemark price target, would be buyers on weakness

Benchmark analyst Mike Hickey lowered the firm’s price target on Cinemark (CNK) to $35 from $40 and keeps a Buy rating on the shares. Cinemark posted “solid top-line results” in Q4, beating revenue estimates, but missed on AEBITDA due to heightened costs, the analyst tells investors. The firm would be buyers on weakness, as it “firmly” believes in the company’s ability to drive revenue growth and generate operating leverage and free cash flow, reiterating Cinemark as a top idea for 2025.